Detalhe da pesquisa
1.
Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study.
Infection
; 51(4): 1093-1102, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36913112
2.
Fibrinogen-like protein 2 in gastrointestinal stromal tumour.
J Cell Mol Med
; 26(4): 1083-1094, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029030
3.
Early myocardial oedema can predict subsequent cardiomyopathy in high-dose anthracycline therapy.
ESC Heart Fail
; 10(1): 616-627, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36404640
4.
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial.
Clin Cancer Res
; 29(17): 3313-3319, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014660
5.
Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022.
Vaccine
; 41(2): 290-293, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509640
6.
Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic.
Oncol Res Treat
; 44(3): 71-75, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33333506
7.
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up.
JAMA Oncol
; 6(8): 1241-1246, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469385
8.
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 3(5): 602-609, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334365
9.
Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?
Eur J Cancer
; 59: 128-133, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27033260
10.
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.
J Clin Oncol
; 34(3): 244-50, 2016 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26527782
11.
Molecular targeted therapy of gastrointestinal stromal tumors.
Curr Cancer Drug Targets
; 11(6): 688-97, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21599631
12.
A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.
Clin Cancer Res
; 15(18): 5910-6, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19723647